Venture Investors is a member of the Wisconsin Technology Council. 

Venture Investors Health Fund of Madison has co-led a $21.5 million Series B financing round in an Atlanta firm that develops technology for identifying and treating autism, according to an early April press release.

Venture Investors teamed with Nexus NeuroTech Ventures of San Francisco to lead the investment in EarliTec Diagnostics Inc., founded by researchers from Children’s Healthcare of Atlanta, Emory University School of Medicine and Yale University in 2019.

Earlitec plans to use the funds to expand commercialization and clinical research for its early autism diagnostic tool — called the EarliPoint Evaluation — for children ages 16 to 30 months.

Click here to read the full article.